Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls

BACKGROUND: Familial adenomatous polyposis (FAP) is a disease characterized by the development of hundreds to thousands of adenomatous polyps in the colorectum early in life. Virtually all patients with FAP will develop colorectal cancer before the age of 40 to 50 years, unless prophylactic colectom...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Orphanet J Rare Dis
Main Authors: van Heumen, Bjorn WH, Roelofs, Hennie MJ, te Morsche, René HM, Nagengast, Fokko M, Peters, Wilbert HM
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225600/
https://ncbi.nlm.nih.gov/pubmed/24245549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-181
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki